{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T05:31:00Z","timestamp":1792992660876,"version":"4.5.0"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T00:00:00Z","timestamp":1496361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0178713","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T13:49:35Z","timestamp":1496411375000},"page":"e0178713","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials"],"prefix":"10.1371","volume":"12","author":[{"given":"Diana","family":"Thomas Manapurathe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti Murali","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Dewdney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Vaughan","family":"Moxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Biros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2877-8194","authenticated-orcid":true,"given":"Jonathan","family":"Golledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,6,2]]},"reference":[{"issue":"6","key":"ref1","first-page":"397","article-title":"Peripheral arterial disease: diagnosis and management in general practice","volume":"42","author":"TB Au","year":"2013","journal-title":"Aust Fam Physician"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"11294","DOI":"10.3390\/ijms160511294","article-title":"A review of the pathophysiology and potential biomarkers for peripheral artery disease","volume":"16","author":"SM Krishna","year":"2015","journal-title":"Int J Mol Sci"},{"issue":"9901","key":"ref3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"FGR Fowkes","year":"2013","journal-title":"Lancet"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4065\/mcp.2010.0133","article-title":"Peripheral artery disease: current insight into the disease and its diagnosis and management","volume":"85","author":"J. W. Olin","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"1 Pt 2","key":"ref5","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)","volume":"31","author":"JA Dormandy","year":"2000","journal-title":"J Vasc Surg"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11906-007-0034-2","article-title":"How to treat hypertension in patients with peripheral artery disease","volume":"9","author":"DL Clement","year":"2007","journal-title":"Curr Hypertens Rep"},{"issue":"9859","key":"ref7","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"SS Lim","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"ref8","first-page":"233","article-title":"Prevalence of peripheral arterial occlusive disease and associated risk factors in a sample of southern Sardinian population","volume":"13","author":"F Binaghi","year":"1994","journal-title":"Int Angiol"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/PL00013161","article-title":"Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong","volume":"23","author":"SW Cheng","year":"1999","journal-title":"World J Surg"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0890-5096(06)60789-9","article-title":"An atherosclerosis risk factor assessment program for patients with peripheral arterial occlusive disease","volume":"2","author":"KW Johnston","year":"1988","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"ref11","first-page":"218","article-title":"Prevalence of risk factors in patients with peripheral arterial disease. A clinical and epidemiological evaluation","volume":"11","author":"S Novo","year":"1992","journal-title":"Int Angiol"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0021-9150(95)05657-2","article-title":"Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the ADEP study","volume":"120","author":"F Violi","year":"1996","journal-title":"Atherosclerosis"},{"issue":"8829","key":"ref13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0140-6736(92)92889-N","article-title":"Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions","volume":"340","author":"S Yusuf","year":"1992","journal-title":"Lancet"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"MA Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"PA James","year":"2014","journal-title":"JAMA"},{"issue":"22","key":"ref16","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","article-title":"ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)","volume":"32","author":"M Tendera","year":"2011","journal-title":"Eur Heart J"},{"issue":"14","key":"ref17","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jacc.2013.01.004","article-title":"Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF\/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"TW Rooke","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"8560","key":"ref18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(87)92441-X","article-title":"Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication","volume":"2","author":"DH Roberts","year":"1987","journal-title":"Lancet"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2125.1984.tb05027.x","article-title":"Chronic effects of metoprolol and methyldopa on calf blood flow in intermittent claudication","volume":"18","author":"M Lepantalo","year":"1984","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.eurheartj.a061440","article-title":"Lack of influence of propranolol and metoprolol on walking distance in patients with chronic intermittent claudication","volume":"4","author":"MG Bogaert","year":"1983","journal-title":"Eur Heart J"},{"issue":"6","key":"ref21","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.CIR.72.6.1226","article-title":"Effect of beta-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease","volume":"72","author":"WR Hiatt","year":"1985","journal-title":"Circulation"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/archinte.1991.00400090063012","article-title":"Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials","volume":"151","author":"K Radack","year":"1991","journal-title":"Arch Intern Med"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.CIR.95.2.411","article-title":"Effect of verapamil in intermittent claudication A randomized, double-blind, placebo-controlled, cross-over study after individual dose-response assessment","volume":"95","author":"JP Bagger","year":"1997","journal-title":"Circulation"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/bjs.9198","article-title":"Randomized clinical trial of angiotensin-converting enzyme inhibitor, ramipril, in patients with intermittent claudication","volume":"100","author":"Y Shahin","year":"2013","journal-title":"Br J Surg"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00392-010-0184-0","article-title":"Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease","volume":"99","author":"AR Zankl","year":"2010","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/000331978503600505","article-title":"Captopril for the treatment of patients with hypertension and peripheral vascular disease","volume":"36","author":"M Catalano","year":"1985","journal-title":"Angiology"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/030006059202000403","article-title":"Isradipine in the treatment of peripheral occlusive vascular disease of the lower limbs: a pilot study","volume":"20","author":"M Catalano","year":"1992","journal-title":"J Int Med Res"},{"issue":"1","key":"ref28","first-page":"23","article-title":"Angiotensin-converting enzyme inhibition with cilazapril does not improve blood flow, walking time, or plasma lipids in patients with intermittent claudication","volume":"4","author":"JD Spence","year":"1993","journal-title":"J Vasc Med Biol"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0741-5214(98)70067-9","article-title":"A randomized, double-blind, placebo-controlled, crossover study to assess the immediate effect of sublingual glyceryl trinitrate on the ankle brachial pressure index, claudication, and maximum walking distance of patients with intermittent claudication","volume":"28","author":"SR Walker","year":"1998","journal-title":"J Vasc Surg"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/000331979004100802","article-title":"Placebo-controlled, double-blind study of the effect of verapamil in intermittent claudication","volume":"41","author":"H-H Kimose","year":"1990","journal-title":"Angiology"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00044011-199700131-00017","article-title":"Antihypertensive efficacy of amlodipine and enalapril and effects on peripheral blood flow in patients with essential hypertension and intermittent claudication","volume":"13","author":"E Casiglia","year":"1997","journal-title":"Clin Drug Invest"},{"issue":"1 Pt 2","key":"ref32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0002-8703(91)90874-H","article-title":"A multicenter study of doxazosin in the treatment of patients with mild or moderate essential hypertension and concomitant intermittent claudication","volume":"121","author":"M Catalano","year":"1991","journal-title":"Am Heart J"},{"key":"ref33","first-page":"CD003075","article-title":"Treatment of hypertension in peripheral arterial disease","volume":"12","author":"DA Lane","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"D Moher","year":"2015","journal-title":"Syst Rev"},{"key":"ref35","article-title":"Cochrane handbook for systematic reviews of interventions","author":"JPT Higgins","year":"2011"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"KF Schulz","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2288-9-80","article-title":"Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data","volume":"9","author":"BC Wallace","year":"2009","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0002-9343(94)90022-1","article-title":"ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group","volume":"97","author":"A Overlack","year":"1994","journal-title":"Am J Med"},{"issue":"17","key":"ref39","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1161\/01.CIR.100.17.e75","article-title":"Transatlantic Conference on Clinical Trial Guidelines in Peripheral Arterial Disease: clinical trial methodology. Basel PAD Clinical Trial Methodology Group","volume":"100","author":"KH Labs","year":"1999","journal-title":"Circulation"},{"issue":"7259","key":"ref40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1136\/bmj.321.7259.504","article-title":"Statistics notes: blinding in clinical trials and other studies","volume":"321","author":"SJ Day","year":"2000","journal-title":"BMJ"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"KF Schulz","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"DR Elbourne","year":"2002","journal-title":"Int J Epidemiol"},{"issue":"22","key":"ref43","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A Randomized Trial of Intensive versus Standard Blood-Pressure Control","volume":"373","author":"JT Wright Jr.","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"ref44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.atherosclerosis.2013.09.037","article-title":"Meta-analysis of angiotensin converting enzyme inhibitors effect on walking ability and ankle brachial pressure index in patients with intermittent claudication","volume":"231","author":"Y Shahin","year":"2013","journal-title":"Atherosclerosis"},{"issue":"5","key":"ref45","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jama.2012.216237","article-title":"Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial","volume":"309","author":"AA Ahimastos","year":"2013","journal-title":"JAMA"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-144-9-200605020-00009","article-title":"Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial","volume":"144","author":"AA Ahimastos","year":"2006","journal-title":"Ann Intern Med"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijsu.2010.12.006","article-title":"Do angiotensin converting enzyme inhibitors improve walking distance in patients with symptomatic lower limb arterial disease? A systematic review and meta-analysis of randomised controlled trials","volume":"9","author":"Y Shahin","year":"2011","journal-title":"Int j surg"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ehj.2003.10.033","article-title":"Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease","volume":"25","author":"J Ostergren","year":"2004","journal-title":"Eur Heart J"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/HYPERTENSIONAHA.109.142240","article-title":"Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR\/Trandolapril STudy","volume":"55","author":"AA Bavry","year":"2010","journal-title":"Hypertension"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0178713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T09:52:19Z","timestamp":1569405139000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0178713"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,2]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0178713","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,2]]}}}